A detailed history of North Star Investment Management Corp. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, North Star Investment Management Corp. holds 15,675 shares of ATAI stock, worth $18,653. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,675
Holding current value
$18,653
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$1.16 - $1.64 $18,183 - $25,707
15,675 New
15,675 $18,000
Q2 2023

Aug 02, 2023

BUY
$1.44 - $2.19 $22,219 - $33,791
15,430 New
15,430 $26,000
Q3 2022

Nov 02, 2022

SELL
$3.14 - $4.87 $5,338 - $8,279
-1,700 Reduced 94.44%
100 $0
Q2 2022

Jul 19, 2022

BUY
$3.03 - $5.32 $2,424 - $4,256
800 Added 80.0%
1,800 $7,000
Q4 2021

Feb 07, 2022

BUY
$6.82 - $17.8 $6,138 - $16,020
900 Added 900.0%
1,000 $8,000
Q3 2021

Oct 20, 2021

BUY
$13.62 - $19.48 $1,362 - $1,948
100 New
100 $1,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $197M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.